Abstract
Mitochondria are very vulnerable to genetic and environmental damage. If a patient is suspected of having a mitochondrial disease, elevated blood lactate, lowered blood free carnitine, abnormal urinary organic acids and carnitine esters and tissue histopathology may help with the diagnosis. For biochemical assessment of the defect, muscle is the tissue of choice even when involvement of other organs like heart or brain is more prominent.
We have studied isolated muscle mitochondria and homogenates from muscle biopsies in 250 patients, and have detected in more than one third mitochondrial defects in oxidative phosphorylation, dehydrogenases, non-redox enzymes catalyzing synthesis of fuel molecules and in the carnitine system. Several patients showed more than one defect.
We have selected eight patients to illustrate how a relatively simple series of investigations in both isolated mitochondria and homogenate can be used for the identification of defects in oxidative phosphorylation in a small amount of muscle (200 mg or more). Identification of the defect(s) is important since it may provide the basis for rational treatment. A minority of the patients recovered partly or completely, which is unique in treatment of inborn errors of subcellular organelles.
An important aspect of mitochondrial dysfunction is the tissue specificity. The defect may be systemic but is often clinically expressed in only one or a few tissues. Rarely, tissue-specific defects can be understood on the basis of tissue-specificity of mitochondrial (iso-)enzymes. Mitochondrial deficiencies of all biotin enzymes and most CoA-linked enzymes are expressed in fibroblasts; most respiratory chain defects are not.
When mitochondrial ATP synthesis has been compromised by a mitochondrial defect, secondary lesions may be generated by changes in mitochondrial protein synthesis, activated proteases and phospholipases, increased matrix CoA and resulting carnitine deficiency, decrease in Krebs cycle intermediates and increased free radical formation and lipid peroxidation.
Similar content being viewed by others
References
Argov, Z., Bank, W. J., Maris, J., Elef, S., Kenneway, N. G., Olson, R. E. and Chance, B. Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: a31P-NMR follow-up study.Ann. Neurol. 19 (1986) 598–602
Arts, W. F. M., Scholte, H. R., Bogaard, J. M., Kerrebijn, K. F. and Luyt-Houwen, I. E. M. NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin.Lancet 2 (1983) 581–582
Arts, W. F. M., Scholte, H. R., Loonen, M. C. B., Przyrembel, H., Fernandes, J., Trijbels, J. M. F. and Luyt-Houwen, I. E. M. Cytochromec oxidase deficiency in subacute necrotizing encephalomyelopathy.J. Neurol. Sci. 77 (1987) 103–115
Barth, P. G., Scholte, H. R., Berden, J. A., Van der Klei-Van Moorsel, J. M., Luyt-Houwen, I. E. W., van 't Veer-Korthof, E. Th., Van der Harten, J. J. and Sobotka-Plojhar, M. A. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.J. Neurol. Sci. 62 (1983) 327–355
Bethlem, J. and Knobbout, Ch. E.Neuromuscular Diseases. Oxford University Press (1987) (in press)
Bookelman, H., Trijbels, J. M. F., Sengers, R. C. A. and Janssen, A. M. J., Measurement of cytochromes in human skeletal muscle mitochondria, isolated from fresh and frozen stored muscle specimens.Biochem. Med. 19 (1978) 366–373
Busch, H. F. M., Jennekens, F. G. I. and Scholte, H. R. (eds.)Mitochondria and Muscular Diseases. Mefar B.V., Beetsterzwaag, The Netherlands, 1981a
Busch, H. F. M., Scholte, H. R., Arts, W. F. and Luyt-Houwen, I. E. M. A mitochondrial myopathy with a respiratory chain defect and carnitine deficiency. In Busch, H. F. M., Jennekens, F. G. I. and Scholte, H. R. (eds)Mitochondria and Muscular Diseases. Mefar B. V., Beetsterzwaag, The Netherlands, 1981b, pp. 207–211
Byrne, E. and Trounce, I. Oxygen electrode studies with human skeletal muscle mitochondriain vitro.J. Neurol. Sci. 69 (1985) 319–333
Carafoli, E. and Roman, I. Mitochondria and disease.Mol. Aspects Med. 3 (1980) 295–429
Clark, J. B., Hayes, D. J., Morgan-Hughes, J. A. and Byrne, E. Mitochondrial myopathies: disorders of the respiratory chain and oxidative phosphorylation.J. Inher. Metab. Dis. 7, suppl. 1 (1984) 62–68
Cooperstein, S. J. and Lazarow, A. A microspectrophotometric method for the determination of cytochrome oxidase.J. Biol. Chem. 189 (1951) 665–670
Cornelio, F. and DiDonato, S. Myopathies due to enzyme deficiencies.J. Neurol. 232 (1985) 329–340
Davidson, B. and Schultz, H. Separation, properties and regulation of acyl-CoA dehydrogenase from bovine heart and liver.Arch. Biochem. Biophys. 213 (1982) 155–162
DiMauro, S., Bonilla, E., Zeviani, M., Nakagawa, M. and DiVivo, D. C. Mitochondrial myopathies.Ann. Neurol. 17 (1985) 521–538
Douglas, C. E., Chan, A. C. and Choy, P. C. Vitamin E inhibits platelet phospholipase A2.Biochim. Biophys. Acta 876 (1986) 639–645
Engel, A. G. Carnitine deficiency syndromes and lipid storage myopathies. In Engel, A. G. and Banker, B. Q. (eds.)Myology. McGraw-Hill Book Cy., New York, 1986, pp. 1663–1696
Engel, A. G. and Banker, B. Q. (eds.)Myology. McGraw-Hill Book Cy., New York, 1986
Engel, A. G. and Dale, A. J. D. Autophagic glycogenosis of late onset with mitochondrial abnormalities: light and electron microscopic observations.Mayo Clin. Proc. 43 (1968) 233–279
Fischer, J. C.Mitochondrial Myopathies and Respiratory Chain-Defects, Academic Thesis, University of Nijmegen, Stichting Studentenpers, Nijmegen, The Netherlands, 1985
Fischer, J. C., Ruitenbeek, W., Gabreëls, F. J. M., Janssen, A. J. M., Renier, W. O, Sengers, R. C. A., Stadhouders, A. M., ter Laak, H. J., Trijbels, J. M. F. and Veerkamp, J. H. A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q.Eur. J. Pediatr. 144 (1986a) 441–444
Fischer, J. C., Ruitenbeek, W., Trijbels, J. M. F., Veerkamp, J. H., Stadhouders, A. M., Sengers, R. C. A. and Janssen, A. M. J. Estimation of NADH oxidation in human skeletal muscle mitochondria.Clin. Chim. Acta 155 (1986b) 263–274
Folkers, K., Wolaniuk, J., Simonsen, R., Morishita, M. and Vadhanavikit, S. Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q.Proc. Natl. Acad. Sci. U.S. 82 (1985) 4513–4516
Goldfisher, S., Moore, C. L., Johnson, A. B., Spiro, A. J., Valsamis, M. P., Wisniewski, H. K., Ritch, R. H., Norton, W. T., Rapin, I. and Gartner, L. M. Peroxysomal and mitochondrial defect in the cerebrohepatorenal syndrome.Science 182 (1973) 62–64
Huijmans, J. G. M., Scholte, H. R., Blom, W., Luyt-Houwen, I. E. M. and Przyrembel, H. Enzymatic evidence for a medium-chain acyl-CoA dehydrogenase deficiency in muscle of a patient with hypoketotic hypoglycemic dicarboxylic aciduria.Pediatr. Res. 18 (1984) 798
Idell-Wenger, J. A., Grotyohann, L. W. and Neely, J. R. Coenzyme A and carnitine distribution in normal and ischemic hearts.J. Biol. Chem. 253 (1978) 4310–4318
King, T. E. Ubiquinone proteins in cardiac mitochondria. In Trumpower, B. L. (ed.)Function of Quinones in Energy Conserving Systems. Academic Press, New York, 1982, pp. 3–25
Land, J. M. and Clark, J. B. Mitochondrial myopathies.Biochem. Soc. Trans. 7 (1979) 231–245
Lauquin, G. J. M., Villiers, C., Michejda, J. W., Hrniewiecka, L. V. and Vignais, P. V. Adenine nucleotide transport in sonic sub-mitochondrial particles: kinetic properties and binding of specific inhibitors.Biochim. Biophys. Acta 460 (1977) 331–345
McKusick, V. A.Mendelian Inheritance in Man. Johns Hopkins University Press, Baltimore, 1986
Meijer, A. J. Anion translocation in mitochondria.PhD thesis, University of Amsterdam, Academic Service, Amsterdam, 1971
Miyabayashi, S., Narisawa, K., Tada, K., Sakai, K., Kobayashi, K. and Kobayashi, Y. Two siblings with cytochromec oxidase deficiency.J. Inher. Metab. Dis. 6 (1983) 121–122
Mooy, P. D., Giesberts, M. A. H., Van Gelderen, H. H., Scholte, H. R., Luyt-Houwen, I. E. M., Przyrembel, H. and Blom, W. Glutaric aciduria type II: multiple defects in isolated muscle mitochondria and deficient beta-oxidation in fibroblasts.J. Inher. Metab. Dis. 7, suppl. 2 (1984) 101–102
Morgan-Hughes, J. A. Defects of the energy pathways of skeletal muscle. In Matthews, W. B. and Glaser, J. H. (eds.)Recent Advances in Clinical Neurology. 3rd Edn., Churchill Livingstone, Edinburgh, 1982, 1–46
Morgan-Hughes, J. A. The mitochondrial myopathies. In Engel, A. G. and Banker, B. Q. (eds.)Myology. McGraw-Hill Book Cy., New York, 1986a, 1709–1743
Morgan-Hughes, J. A. Mitochondrial diseases.Trends Neurol. Sci. 9 (1986b) 15–19
Nohl, H., Jordan, W. and Hegner, D. Mitochondrial formation of OH radicals by an ubisemiquinone-dependent reaction. An alternative pathway to the iron-catalyzed Haber-Weiss cycle.Hoppe-Seyler's Z. Physiol. Chem. 363 (1982) 599–607
Ogasahara, S., Nishikawa, Y., Yorifuji, S., Soga, F., Nakamura, Y., Takahashi, M., Hashimoto, S., Kono, N. and Tarui, S. Treatment of Kearns-Sayre syndrome with coenzyme Q10.Neurology 36 (1986) 45–53
Przyrembel, H., Scholte, H. R., Busch, H. F. M., Blom, W., Arts, W. F. M. and Luyt-Houwen, I. E. M. Chronic lactic acidaemia and lipid myopathy due to cytochromec 1 deficiency in liver and skeletal muscle; treatment with vitamin C. In Scarlato, G. and Cerri, C. (eds.)Mitochondrial Pathology in Muscle Diseases. Piccin Med. Books, Padua, Italy, 1983, pp. 193–195
Przyrembel, H., Scholte, H. R., Busch, H. F. M., Blom, W., Arts, W. F. M., Luyt-Houwen, I. E. M. and Berden, J. A. Cytochrome (cyt)c 1 deficiency in liver and muscle mitochondria.Pediatr. Res. 18 (1984) 797
Robinson, B. H., Ward, J., Goodyer, P. and Baudet, A. Respiratory chain defects in the mitochondria of cultured skin fibroblasts from three patients with lacticacidemia.J. Clin. Invest. 77 (1986) 1422–1427
Scarlato, G. and Cerri, C. (ed.),Mitochondrial Pathology in Muscle Diseases. Piccin Med. Books, Padua, Italy, 1983
Schewe, T., Albracht, S. P. J. and Ludwig, P. On the site of action of the inhibition of the mitochondrial respiratory chain by lipoxygenase.Biochim. Biophys. Acta 636 (1981) 210–217
Scholte, H. R. Carnitine in health and disease.Neuropediatrics, 14 (1983) 129
Scholte, H. R., Busch, H. F. M., Barth, P. G., Beekman, R. P., Berden, J. A., Duran, M., Luyt-Houwen, I. E. M., Przyrembel, H., Roth, B. and De Vries, S. Carnitine deficiency and mitochondrial respiratory chain blockade. In Scarlato, G. and Cerri, C. (eds.)Mitochondrial Pathology in Muscle Diseases. Piccin Med. Books, Padua, Italy, 1983, 215–228
Scholte, H. R., Busch, H. F. M. and Luyt-Houwen, I. E. M. Functional disorders of mitochondria in muscular diseases — respiratory chain phosphorylation — the carnitine system. In Busch, H. F. M., Jennekens, F. G. I. and Scholte, H. R. (eds.)Mitochondria and Muscular Diseases. Mefar, B. V., Beetsterzwaag, The Netherlands, 1981, pp. 133–145
Scholte, H. R. and de Jonge, P. C. Metabolism, function and transport of carnitine in health and disease. In Gitzelmann, R.et al. (eds.)Carnitin in der Medizin. Schattauer Verlag, Stuttgart, 1987, pp. 21–59
Scholte, H. R. and Groot, P. H. E. Organ and intracellular localization of short-chain acyl-CoA synthetases in rat and guinea pig.Biochim. Biophys. Acta 409 (1975) 283–296
Scholte, H. R., Luyt-Houwen, I. E. M. and Busch, H. F. M. Difficulties in assessing biochemical properties of abnormal muscle mitochondria.J. Inher. Metab. Dis. 8, suppl. 2 (1985) 149–150
Scholte, H. R., Luyt-Houwen, I. E. M., Busch, H. F. M. and Vaandrager-Verduin, M. H. M. Biochemical criteria for NADH-CoQ reductase deficiency.Ann. N.Y. Acad. Sci. 488 (1986) 513–516
Schultheiss, H. P. and Bolte, H. D. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy.J. Mol. Cell. Cardiol. 17 (1985) 603–617
Schultheiss, H.-P., Schulze, K. and Klingenberg, M. The ADP/ATP carrier as a mitochondrial auto-antigen: facts and perspectives.Ann. N.Y. Acad. Sci 488 (1986) 44–63
Sengers, R. C. A., Stadhouders, A. M. and Trijbels, J. M. F. Mitochondrial myopathies: clinical, morphological and biochemical aspects,Eur. J. Pediatr. 141 (1984) 192–207
Shug, A. L., Thomson, J. D., Folts, J. D., Bittar, N., Klein, M. I., Koke, J. R. and Huth, P. J. Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia.Arch. Biochem. Biophys. 187 (1978) 25–33
Stumpf, D. A. Mitochondrial multisystem disorders. Clinical, biochemical and morphological features. In Tyler, H. R. and Daeson, D. M. (eds.)Current Neurology. Vol. 2, Houghton-Mifflin Professional Publishers, Boston, 1979, pp. 117–149
Tager, J. M., Wanders, R. J. A., Groen, A. K., Kunze, W., Bohnensack, R., Küster, U., Letko, G., Böhme, G., Duszynski, J. and Wojtczak, L. Control of mitochondrial respiration.FEBS Lett. 151 (1983) 1–9
Toifl, K., Scholte, H. R., Sluga, E. and Vass, B. Diet therapy in a rare case of mitochondrial myopathy.Muscle Nerve 9 (1986) 184
Trijbels, J. M. F., Berden, J. A, Monnens, L. A. H., Willems, J. L., Janssen, A. J. M., Schutgens, R. B. H. and van den Broek-van Essen, M. Biochemical studies in the liver and muscle of patients with Zellweger syndrome.Pediatr. Res. 17 (1983) 514–517
Turrens, J. F. and Boveris, A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria.Biochem. J. 191 (1980) 421–427
Walter, G. F. Myoencephalopathies with abnormal mitochondria: a review.Clin. Neuropathol. 2 (1983) 101–113
Wiesner, R., Ludwig, P., Schewe, T. and Rapoport, S. M. Reversibility of the inhibition of cytochromec oxidase by reticulocyte lipoxygenase.FEBS Lett. 123 (1981) 123–126
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scholte, H.R., Busch, H.F.M., Luyt-Houwen, I.E.M. et al. Defects in oxidative phosphorylation. Biochemical investigations in skeletal muscle and expression of the lesion in other cells. J Inherit Metab Dis 10 (Suppl 1), 81–97 (1987). https://doi.org/10.1007/BF01812849
Issue Date:
DOI: https://doi.org/10.1007/BF01812849